LENSAR, Inc.
LNSRNasdaqCIK 1320350HealthcareFiscal year ends Dec 31
Reports and events: 97 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1316:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349315 |
| 2026-08-1307:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-347859 |
| 2026-08-1016:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-342330 |
| 2026-06-2316:20 ET | DEF 14A | Proxy statementPeriod 2026-06-23 | 0001193125-26-279484 |
| 2026-05-2916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events | 0001193125-26-248230 |
| 2026-05-0816:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-214571 |
| 2026-05-0807:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213268 |
| 2026-04-3016:30 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-197477 |
| 2026-04-1516:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-157105 |
| 2026-03-3116:14 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-134587 |
| 2026-03-3106:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-133153 |
| 2026-03-1708:26 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-109458 |
| 2026-03-1306:02 ET | 8-K/A | 8.01 Other events | 0001193125-26-104937 |
| 2026-03-1216:17 ET | 8-K | 8.01 Other events | 0001193125-26-104194 |
| 2026-02-2517:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-072059 |
| 2025-12-1916:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-326777 |
| 2025-11-0616:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269428 |
| 2025-11-0607:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268073 |
| 2025-11-0507:00 ET | DEF 14A | Proxy statementPeriod 2025-10-24 | 0001193125-25-265686 |
| 2025-10-2116:30 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001193125-25-245196 |
| 2025-08-0716:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001320350-25-000004 |
| 2025-08-0707:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104556 |
| 2025-07-0216:00 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-092921 |
| 2025-05-2216:43 ET | 8-K | 8.01 Other events | 0001193125-25-125116 |
| 2025-05-0816:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066964 |
| 2025-05-0816:01 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000950170-25-066893 |
| 2025-05-0807:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066375 |
| 2025-04-3016:05 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-061029 |
| 2025-03-2521:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-044695 |
| 2025-03-2408:11 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-060906 |
| 2025-02-2716:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029003 |
| 2025-02-2707:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-028363 |
| 2024-11-0717:25 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123534 |
| 2024-11-0707:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122790 |
| 2024-08-0816:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093862 |
| 2024-08-0807:30 ET | 8-K | 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093326 |
| 2024-05-1316:00 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-058603 |
| 2024-05-0916:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056837 |
| 2024-05-0907:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056284 |
| 2024-05-0816:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-055579 |
| 2024-03-2506:03 ET | DEF 14A | Proxy statementPeriod 2024-05-07 | 0000950170-24-035579 |
| 2024-03-0416:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-024807 |
| 2024-03-0407:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-024351 |
| 2024-02-2616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-020190 |
| 2024-02-0616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-011745 |
| 2023-11-0916:35 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062153 |
| 2023-11-0907:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061532 |
| 2023-10-1307:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-053209 |
| 2023-08-0916:29 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040659 |
| 2023-08-0907:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040141 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.